1. Metabolic-Associated Fatty Liver Disease and Sarcopenia.
- Author
-
Bali T, Chrysavgis L, and Cholongitas E
- Subjects
- Humans, Obesity complications, Risk Assessment, Sarcopenia complications, Sarcopenia epidemiology, Non-alcoholic Fatty Liver Disease complications
- Abstract
The current evidence indicates a strong association between sarcopenia, the loss of muscle mass and strength, and metabolic-associated fatty liver disease (MAFLD). The two entities share many common pathophysiologic mechanisms, and their coexistence may result in higher rates of morbidity and mortality. Therefore, given their increasing incidence in the modern world, there is a need for a better understanding of the liver-muscle axis for early identification of sarcopenia in patients with MAFLD and vice versa. This review aims at presenting current data regarding the correlation between sarcopenia and MAFLD, the associated comorbidities, and the need for effective therapies., Competing Interests: Conflict-of-interest No potential conflicts of interest. No financial support., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF